The program of the Division of Nuclear Medicine focuses on clinical service, research and education involving the medical use of radiopharmaceuticals. A dedicated and experienced faculty of 31 physicians and scientists leads this program.

In the Nuclear Medicine Clinic, patients benefit from state-of-the-art procedures that include the latest instruments, computers and drugs for diagnosis and treatment of diseases using radiopharmaceuticals. The clinical program is broadly based, but there is a major emphasis on cancer and heart disease. Comprehensive facilities of the Adult (10,000 square feet) and Pediatric (2000 square feet) Nuclear Medicine Clinics include 9 SPECT tomographs and 2 state-of-the-art PET and PET/CT scanners devoted to patient care and clinical research. Imaging is closely integrated into the Picture Archiving and Communications System of the Department of Radiology.

The Nuclear Medicine research program is a broad one, but is especially strong in introducing new radiotracer imaging methods to detect earliest neurochemical alterations in degenerative brain disorders. Space dedicated for Nuclear Medicine research (18,000 square feet) is in the adjacent Kresge Research and Medical Science buildings. These house a complete cyclotron/radioassay chemistry laboratory plus laboratories for image analysis, image instrument development and small animal study. MicroPET, primate PET, and SPECT units provide for research animal imaging. Research grants within the Division of Nuclear Medicine total about $6,000,000 annually.

For more information, please contact Kirk A. Frey, M.D. Program Director, or Lorraine M. Fig, M.D., MPH, Associate Director, Nuclear Medicine Division.